Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treat-to-target TRAb-guided carbimazole versus fixed-duration carbimazole in Graves' disease
ACTRN12615000362594Phase 4Terminated
- Sponsor
- Royal Brisbane & Women's Hospital Foundation
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of carbimazole in Graves' disease (2 arms), sponsored by Royal Brisbane & Women's Hospital Foundation. Primary endpoint: Relapse of hyperthyroidism. Started Jun 2015; status: terminated.
02
Drugs
carbimazole
03
Conditions
Graves' disease
Beyond the preview
Go deeper on ACTRN12615000362594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000362594.